To evaluate the efficacy and safety of OnabotulinumtoxinA treatment in the management of overactive bladder syndrome.
A systematic review of the literature and meta-analysis was performed including randomized controlled clinical trials that compared the use of OnabotulinumtoxinA with placebo, antimuscarinic medication, or different doses of OnabotulinumtoxinA.